What is Prostate Cancer?
Prostate cancer is the most common non-skin cancer in men and it affects the prostate gland and may spread to surrounding structures.
While most men with prostate cancer may experience little to no symptoms, the common symptoms include:
- Difficulty urinating
- Low force/power when urinating
- Bloody urine
- Bloody semen
- Pain in bones
- Erectile dysfunction
- Excessive weight loss
Are you at risk for prostate cancer?Assess My Risk
Nearly one in six American men will be diagnosed with prostate cancer during his lifetime. With greater awareness, prostate cancer detection is on the rise and mortality is declining. Prostate cancer can be detected during a regular checkup, using a combination of a blood test called a PSA and a digital rectal exam (DRE).
If you have an early diagnosis of prostate cancer, there is usually a range of treatment options. These may include conservative management, radiation therapy with external bream or brachytherapy therapy, cryosurgery, and prostatectomy - surgical removal of the prostate. Your treatment options will depend on a number of factors, including the stage of the disease, your age, health or personal preference.
Types of Treatment
Robotic Radical Prostatectomy
We offer treatment with surgeons trained in the daVinci minimally invasive robotic surgery. This allows the surgeon to operate using robotic tools inserted through several small incisions, minimizing the blood loss and recovery time of prostate surgeries.
External Beam Irradiation
We are equipped with an advanced Elekta Infinity linear accelerator capable of treating the brain and spine with high precision. The Elekta Infinity linac offers volumetric modulated arc therapy (VMAT), which often provides faster and more precise radiation delivery to the brain and spine.
Patients with widespread metastatic prostate cancer may benefit from systemic therapy with radioactive isotopes, including Samarium-153 (Quadramet) and Radium-223 (Xofigo).
We offer androgen deprivation therapy (ADT) for prostate cancers. This well-established treatment modality is known to benefit patients with high-risk localized cancers, as well as patients with metastatic disease.